You're one step closer to unlocking our suite of comprehensive and robust tools.
Fill out the form so we can connect you to the right person.
Actinium Pharmaceuticals appoints analytical development director
U.S. Smart Cities Projects To Push Annual Revenue Over $700 Million In Five-Year Outlook
Cable Net Valuation Benchmarks Hit Recent Low In CBS-Viacom Deal
MI Mobile App
Independent Networks Gain Little Traction On Virtual Multichannel Services
Actinium Pharmaceuticals Inc. appointed Jeannine Larrieux director of analytical development.
Larrieux will oversee analytical assay development, biologics license applications and investigational new drug-enabling studies.
Larrieux previously worked as the head of analytical science and technology at Novartis.